Tue, March 27, 2012
Mon, March 26, 2012
Sun, March 25, 2012
Sat, March 24, 2012
Fri, March 23, 2012
Thu, March 22, 2012
Wed, March 21, 2012
Tue, March 20, 2012
Mon, March 19, 2012
Sun, March 18, 2012
Fri, March 16, 2012
Thu, March 15, 2012
Wed, March 14, 2012
Tue, March 13, 2012

Aeterna Zentaris to Announce Fourth Quarter and Full Year 2011 Financial and Operating Results on March 27, 2012


//health-fitness.news-articles.net/content/2012/ .. cial-and-operating-results-on-march-27-2012.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Aeterna Zentaris to Announce Fourth Quarter and Full Year 2011 Financial and Operating Results on March 27, 2012

Aeterna Zentaris to Announce Fourth Quarter and Full Year 2011 Financial and Operating Results on March 27, 2012

[ ]

QUEBEC CITY, March 20, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: [ AEZS ]) (TSX: AEZ) (the "Company") will announce its fourth quarter and full year 2011 financial and operating results on Tuesday, March 27, 2012. The Company will host a conference call and webcast to discuss these results on Wednesday, March 28 at 8:30 a.m., Eastern Time.

Participants may access the live webcast via the Company's website at [ www.aezsinc.com ] in the "Newsroom" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. For more information please visit [ www.aezsinc.com ].

SOURCE AETERNA ZENTARIS INC.

[ Back to top ]


Publication Contributing Sources